---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-015192"
form_type: "8-K"
ticker: "RNXT"
cik: "0001574094"
company_name: "RenovoRx, Inc."
filed_at: "2024-04-18T23:59:59+00:00"
generated_at: "2026-06-03T18:53:39.088194+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# RenovoRx regains Nasdaq compliance after $17.2M fundraising; hearing cancelled

## Summary
- Nasdaq confirmed RenovoRx met $2.5M minimum stockholders' equity requirement; prior deficiency remedied.
- Company raised $17.2M in gross proceeds in 2024, extending cash runway into 2026.
- Hearing before Nasdaq Hearings Panel cancelled; no ongoing monitor required.
- Management to focus on Phase III TIGeR-PaC trial progress, TAMP pipeline expansion, and business development.

## SEC filing metadata
- accession: 0001493152-24-015192
- form_type: 8-K
- ticker: RNXT
- cik: 0001574094
- company_name: RenovoRx, Inc.
- filed_at: 2024-04-18T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1574094/000149315224015192/0001493152-24-015192-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1574094/000149315224015192/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-015192
- JSON: https://secwatch.observer/filing/0001493152-24-015192.json
- Plain text: https://secwatch.observer/filing/0001493152-24-015192.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.